Skip to content
DataLookout
Menu

Terremoto Biosciences Inc. clinical trial pipeline

Get alerts when Terremoto Biosciences Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: TER-2013 · Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations Primary endpoint(s) modified Terremoto Biosciences Inc.Phase 1/2 NCT07109726
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1/2
1
Get alerts when Terremoto Biosciences Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free